Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer's disease

A Taubes, P Nova, KA Zalocusky, I Kosti, M Bicak… - Nature Aging, 2021 - nature.com
The evident genetic, pathological and clinical heterogeneity of Alzheimer's disease (AD)
poses challenges for traditional drug development. We conducted a computational drug …

Navigating the complexities of drug development for inflammatory bowel disease

S Honap, V Jairath, S Danese… - Nature Reviews Drug …, 2024 - nature.com
Inflammatory bowel disease (IBD)—consisting of ulcerative colitis and Crohn's disease—is a
complex, heterogeneous, immune-mediated inflammatory condition with a multifactorial …

Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment

AB Nagaraj, QQ Wang, P Joseph, C Zheng, Y Chen… - Oncogene, 2018 - nature.com
Computation-based drug-repurposing/repositioning approaches can greatly speed up the
traditional drug discovery process. To date, systematic and comprehensive computation …

[HTML][HTML] Drug repurposing for glioblastoma based on molecular subtypes

Y Chen, R Xu - Journal of biomedical informatics, 2016 - Elsevier
A recent multi-platform analysis by The Cancer Genome Atlas identified four distinct
molecular subtypes for glioblastoma (GBM) and demonstrated that the subtypes correlate …

[HTML][HTML] Computational drug repurposing for inflammatory bowel disease using genetic information

L Grenier, P Hu - Computational and structural biotechnology journal, 2019 - Elsevier
As knowledge of the genetics behind inflammatory bowel disease (IBD) has continually
improved, there has been a demand for methods that can use this data in a clinically …

[HTML][HTML] Systems biology in inflammatory bowel diseases: on the way to precision medicine

N Dovrolis, E Filidou, G Kolios - Annals of Gastroenterology, 2019 - ncbi.nlm.nih.gov
Inflammatory bowel diseases (IBD) are chronic and recurrent inflammatory disorders of the
gastrointestinal tract. The elucidation of their etiopathology requires complex and multiple …

[HTML][HTML] Disease comorbidity-guided drug repositioning: a case study in schizophrenia

QQ Wang, R Xu - AMIA Annual Symposium Proceedings, 2018 - ncbi.nlm.nih.gov
The key to any computational drug repositioning is the availability of relevant data in
machine-understandable format. While large amount of genetic, genomic and chemical data …

Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer's disease

A Alice Taubes, P Nova, KA Zalocusky, I Kosti, M Bicak… - 2021 - docta.ucm.es
The evident genetic, pathological, and clinical heterogeneity of Alzheimer's disease (AD)
poses challenges for traditional drug development. We conducted a computational drug …

[图书][B] Integrated Computational Drug Discovery Approaches for Neuropsychiatric Disorders

M Zhou - 2020 - search.proquest.com
Neuropsychiatric disorders (NPDs) such as Alzheimer's disease (AD) lead to enormous
societal burdens. Current treatments of NPDs have limitations, and the drug development …

Methods for treating apoe4/4-associated disorders

Y Huang, A Taubes, N Phil, M Sirota - 2019 - Google Patents
WO2019200342A1 - Methods for treating apoe4/4-associated disorders - Google Patents
WO2019200342A1 - Methods for treating apoe4/4-associated disorders - Google Patents …